Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 15;10(10):e040219.
doi: 10.1136/bmjopen-2020-040219.

Cluster-randomised trial of community-based screening for eye disease in adults in Nepal: the Village-Integrated Eye Worker Trial II (VIEW II) trial protocol

Collaborators, Affiliations

Cluster-randomised trial of community-based screening for eye disease in adults in Nepal: the Village-Integrated Eye Worker Trial II (VIEW II) trial protocol

Kieran S O'Brien et al. BMJ Open. .

Abstract

Introduction: The majority of blindness worldwide could be prevented or reversed with early diagnosis and treatment, yet identifying at-risk and prevalent cases of eye disease and linking them with care remain important obstacles to addressing this burden. Leading causes of blindness like glaucoma, diabetic retinopathy and age-related macular degeneration have detectable early asymptomatic phases and can cause irreversible vision loss. Mass screening for such diseases could reduce visual impairment at the population level.

Methods and analysis: This protocol describes a parallel-group cluster-randomised trial designed to determine whether community-based screening for glaucoma, diabetic retinopathy and age-related macular degeneration reduces population-level visual impairment in Nepal. A door-to-door population census is conducted in all study communities. All adults aged ≥60 years have visual acuity tested at the census visit, and those meeting referral criteria are referred to a local eye care facility for further diagnosis and management. Communities are subsequently randomised to a community-based screening programme or to no additional intervention. The intervention consists of a single round of screening including intraocular pressure and optical coherence tomography assessment of all adults ≥60 years old with enhanced linkage to care for participants meeting referral criteria. Four years after implementation of the intervention, masked outcome assessors conduct a repeat census to collect data on the primary outcome, visual acuity. Individuals with incident visual impairment receive a comprehensive ophthalmological examination to determine the cause of visual impairment. Outcomes are compared by treatment arm according to the originally assigned intervention.

Ethics and dissemination: The trial has received ethical approval from the University of California San Francisco Institutional Review Board, Nepal Netra Jyoti Sangh and the Nepal Health Research Council. Results of this trial will be disseminated through publication in peer-reviewed journals and presentation at local and international meetings.

Trial registration number: NCT03752840.

Keywords: age-related macular degeneration; diabetic retinopathy; glaucoma; mass screening; randomised controlled trial.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Trial flow and timeline. The randomisation unit is a group of contiguous small government demographic units (ie, toles) from the same ward, termed a study cluster. Wards are divided into study clusters after the initial census depending on the ward population; sample size calculations are approximations since baseline census activities are ongoing.

References

    1. Flaxman SR, Bourne RRA, Resnikoff S, et al. . Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health 2017;5:e1221–34. 10.1016/S2214-109X(17)30393-5 - DOI - PubMed
    1. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization, 1968: 164.
    1. Tan NYQ, Friedman DS, Stalmans I, et al. . Glaucoma screening: where are we and where do we need to go? Curr Opin Ophthalmol 2020;31:91–100. 10.1097/ICU.0000000000000649 - DOI - PubMed
    1. Polack S, Yorston D, López-Ramos A, et al. . Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapas, Mexico. Ophthalmology 2012;119:1033–40. 10.1016/j.ophtha.2011.11.002 - DOI - PubMed
    1. Chou R, Dana T, Bougatsos C, et al. . Screening for impaired visual acuity in older adults: updated evidence report and systematic review for the US preventive services Task force. JAMA 2016;315:915–33. 10.1001/jama.2016.0783 - DOI - PubMed

Publication types

Associated data